Select Page

Real Stem Cell Therapy Outcomes

Matthew Feshbach CEO AMBROSE Cell Therapy - Real Stem Cell Therapy Outcomes

Click to listen in full to Episode 45 of Living Beyond 120 as AMBROSE CEO Matthew Feshbach delves into real patient stories and the importance of monitoring stem cell therapy outcomes.

CEO and Founder Matthew Feshbach recently returned as a guest on anti-aging and wellness podcast Living Beyond 120 to talk stem cell therapy outcomes and real AMBROSE patient stories.

Why Patient Outcomes Matter

With more than 98 million adults in the United States living with 2 or more chronic conditions, AMBROSE evaluates the common factors of chronic disease and addresses them in a single procedure utilizing patients’ own adult stem and regenerative cells derived from adipose (fat tissue).

AMBROSE operates under Texas “right to try” legislation (House Bill 810, also known as Charlie’s Law) and approaches investigational stem cell treatments at a serious clinical level, offering patients a safe, regulated environment in which to explore stem cells for improved symptoms, function and quality of life. AMBROSE patient outcomes are examined as part of the Adipose Cell Therapy for Chronic Inflammation (ACT-CI) registry study, conducted under said legislation, the purpose of which is to assess the safety, feasibility and effectiveness of using patient’s own cells to treat severe, chronic conditions.

By closely monitoring and reporting on our outcomes, we hope to help more patients gain access to this potentially life-changing therapy and to set a new standard of safety and care in the process.

“Real Stem Cell Therapy Outcomes” – The Interview

In this episode of Living Beyond 120, Dr. Jeffrey R. Gladden, MD, FACC, and host Mark Young talk with Feshbach about real patient stories, delving into stem cell therapy outcomes experienced by patients suffering from serious and debilitating conditions such as:

  • Multi-joint arthritis and facing joint replacement
  • Kidney failure
  • Lung disorders such as COPD and emphysema
  • Neurodegenerative conditions including Alzheimer’s, Parkinson’s and traumatic brain injury

In the hour-long podcast, they also discuss the role and appropriate use of stem cell therapy as well as ways to improve outcomes if they do take advantage of this kind of treatment. Listen to the full podcast here.

About Living Beyond 120

On this podcast focused on health and human longevity, Dr. Jeffrey R. Gladden, MD, FACC, and host Mark Young examine the latest scientific research, technology and bio-hacks to uncover the truth about the human body’s potential for extending both life and health span well past the what most people accept as biological fact. AMBROSE was featured in an earlier episode titled, “Stem Cell Therapy Now.”